Real Health Magazine

Consumer

English

Magazine

Outlet metrics

Domain Authority

Ranking

Global

#3977568

United States

#1273533

Health/Health

#17282

Traffic sources

Monthly visitors

Articles

Gender-Affirming Care May Lead to Better HIV Outcomes for Trans People

1 month ago | realhealthmag.com | Liz Highleyman

Transgender people who receive gender-affirming hormone therapy appear to have better HIV outcomes, according to a new study published in The Lancet HIV. As the proportion of trans and gender-diverse people receiving hormone therapy rose at two primary care clinics, HIV prevalence and the likelihood of not having viral suppression declined. “Gender-affirming care is important for optimizing HIV outcomes among trans people,” the study authors concluded.
CDC Updates Post-Exposure Prophylaxis Guidelines

1 month ago | realhealthmag.com | Liz Highleyman

In a long-awaited update, the Centers for Disease Control and Prevention (CDC) issued new guidelines for HIV post-exposure prophylaxis (PEP) on May 6. The new guidance—the first revision since 2016—now includes more modern antiretrovirals taken for a month after non-occupational exposure, such as sex or injection drug use.
Single HPV Vaccine Dose Offers Good Protection

1 month ago | realhealthmag.com | Liz Highleyman

A single dose of the human papillomavirus (HPV) vaccine appears to provide as much protection as the currently recommended two doses for adolescents, according to findings from a nearly five-year study presented at the American Association for Cancer Research annual meeting (AACR 2025). A simpler schedule could encourage higher vaccination rates in the United States and worldwide.
Cooling or Compressing Hands During Chemo Can Prevent Neuropathy

2 months ago | realhealthmag.com | Liz Highleyman

Women who wear frozen or tight-fitting gloves during taxane-based chemotherapy for breast cancer are less likely to develop painful peripheral neuropathy, according to research published in JAMA Oncology. While both methods were effective, compression is more accessible and may be better tolerated than cold temperature. Cytotoxic chemotherapy is an effective treatment for many types of cancer, but the medications can harm or kill normal cells along with malignant cells, leading to side effects.
NIH Grant Cuts Threaten Progress in HIV Prevention and Treatment

2 months ago | realhealthmag.com | Liz Highleyman

The Trump administration has rescinded hundreds of National Institutes of Health (NIH) research grants, including many that involve HIV and sexually transmitted infections (STIs). Scientists and advocates have filed a lawsuit to stop the cuts, but prospects for continued funding remain uncertain.
Can Broadly Neutralizing Antibodies Keep HIV in Remission?

2 months ago | realhealthmag.com | Liz Highleyman

Broadly neutralizing antibodies (bnAbs) appeared to help keep HIV under control after stopping antiretroviral therapy and may play a role in long-term remission, according to studies presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2025). In the RIO study, three quarters of men who received the bnAbs 3BNC117-LS and 10-1074-LS did not experience viral rebound five months after discontinuing their antiretrovirals, and a third were still in remission at 18 months.
Broadly Neutralizing Antibodies Show Promise for Long-Acting HIV Treatment

Mar 24, 2025 | realhealthmag.com | Liz Highleyman

Broadly neutralizing antibodies (bnAbs) may work well with lenacapavir or cabotegravir in long-acting regimens for HIV treatment, according to two presentations this week at the Conference on Retroviruses and Opportunistic Infections (CROI 2024) in San Francisco. One study showed that teropavimab and zinlirvimab, two bnAbs from Gilead Sciences, worked well in combination with twice-yearly lenacapavir (Sunlenca).
CDC’s Division of HIV Prevention Could Face Reorganization or Elimination

Mar 19, 2025 | realhealthmag.com | Liz Highleyman

The Trump administration may be planning to eliminate or reorganize the Centers for Disease Control and Prevention (CDC) Division of HIV Prevention, possibly as soon as this week, news sources reported late in the day on March 18. Advocates are asking people to call or write to their legislators to urge them to oppose the cuts.
Long-Acting Injectables Work Well for People Without Viral Suppression

Mar 19, 2025 | realhealthmag.com | Liz Highleyman

Long-acting treatment with injectable cabotegravir and rilpivirine (Cabenuva) may be an option for people who are unable to maintain an undetectable viral load on oral antiretroviral treatment, especially if they received enhanced support, according to several studies presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2025) last week in San Francisco.
Is RFK Jr. Behind a Crackdown on Poppers?

Mar 17, 2025 | realhealthmag.com | Liz Highleyman

At least one major seller of poppers has been raided by the Food and Drug Administration (FDA) and other brands shut down their websites and social media last week, according to a report from Fast Company. Some believe the directive may have come from newly appointed health secretary Robert F. Kennedy Jr., who has suggested that poppers cause AIDS.